Can diabetes medicine help with addiction?

Original Title

Potential role of glucagon-like peptide-1 (GLP-1) receptor agonists in substance use disorder: A systematic review of randomized trials.

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

Scientists looked at 5 studies where people with addiction used diabetes drugs called GLP-1RAs, like Exenatide and Dulaglutide, to see if they helped with alcohol or nicotine use.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

GLP-1 receptor agonists reduced substance use in humans, not just animals

Most early evidence for GLP-1RAs and addiction came from animal studies—this review confirms effects in humans, which is a critical step forward.

Practical Takeaways

People with substance use issues and metabolic conditions might benefit from discussing GLP-1RAs with their doctor as part of a broader treatment plan.

low confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.